Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl

Clinical trial NCT05279716 · UNKNOWN

Trial details

NCT number: NCT05279716
Sponsor: Santen Pharmaceutical Asia Pte. Ltd.
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Normal Tension Glaucoma Primary Open-angle Glaucoma Glaucoma, Suspect Ocular Hypertension

Start date: 2022-02-15
Primary completion: 2022-12-08
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.